GLOBUS MEDICAL, INC. (GMED) Operating margin 2016–2025
GLOBUS MEDICAL, INC. (GMED) operating margin by fiscal year — reported operating income divided by reported revenue.
16.3%FY2025 · since FY2016: 27.3% → 16.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 16.3% | +9.7 pp |
| FY2024 | 6.6% | -1.9 pp |
| FY2023 | 8.5% | -13.8 pp |
| FY2022 | 22.3% | +4.3 pp |
| FY2021 | 17.9% | +3.8 pp |
| FY2020 | 14.1% | -7.8 pp |
| FY2019 | 21.9% | -1.9 pp |
| FY2018 | 23.7% | -1.7 pp |
| FY2017 | 25.4% | -1.9 pp |
| FY2016 | 27.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GMED financial trends
GMED RevenueGMED Net incomeGMED Net marginGMED Gross profitGMED Gross marginGMED Operating incomeGMED Operating cash flowGMED Free cash flowGMED Capital expendituresGMED Return on equityGMED Stock buybacksGMED Dividends paidGMED Total assetsGMED Total liabilitiesGMED Shareholders’ equityGMED overview →